Kidney Carcinoma — Trials

Kidney Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,681 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 398
Recruiting: 202
Ph III recruiting: 17
Growth YoY: +1.2%
Industry share: 32%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 701–703 of 703 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00073125	Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma	completed	Phase 2	103	AbbottINDUSTRY	2	Aug 15, 2007	clinicaltrials
NCT00134186	Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer	completed	Phase 2	43	Pharmacyclics LLC.INDUSTRY	1	Mar 5, 2007	clinicaltrials
NCT00151645